Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Life Sciences





Patentees should feel cautious optimism over the EPO Enlarged Board of Appeal’s decision in G2/21, say European patent attorneys
Significant changes to the standard of law are unlikely, say sources, who note that some justices seemed sceptical that the parties disagreed on the legal standard
A technical effect must still be evident in the original patent filing, the EBoA said in its G2/21 decision today, March 23
The England and Wales High Court's judgment comes ahead of a separate hearing concerning one of the patents-in-suit at the EPO
The US government claimed Moderna should be immune from patent infringement under Section 1498, raising questions about when the doctrine applies
Paul Hastings led Mitsubishi Tanabe to victory over Novartis at the International Chamber of Commerce
The Patent Trial and Appeal Board found that claims in a Novartis patent were obvious over the prior art
Scott Frank, the IP CEO at AT&T, officially established the education and awareness-focused organisation after its inaugural board meeting
The claim, filed at the England and Wales High Court, follows lawsuits launched by Moderna in the US and Germany
Novartis’s planned SCOTUS appeal may be a long shot, but the case raises interesting Section 112 and procedural questions, say counsel
In-house panellists weighed up the most disruptive trends in IP, from the TRIPS waiver to the rise of remote working
Pharma counsel can look at suspicious packaging, online sellers and other signs to learn whether products are fake, say sources at Merck, Gilead and Organon
Sponsored

Sponsored

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
The concentration of cases and the preferences of judges motivate firms to file fewer motions, which can be good or bad depending on who you ask
Counsel at innovator and generics brands debate the implications of attacks on product hopping, settlement restrictions, FDA-USPTO collaboration, and more
An EPO Board of Appeal ruling on how patentees can avoid disclosing prior art from clinical trials is welcome, but issues remain for future spats, counsel say
Interviews; Exclusives

Interviews; Exclusives

Law firm Susman Godfrey’s John Lahad explains how his firm and its co-counsel snagged a $42 million verdict for the University of Texas System and TissueGen
Dagg tells Managing IP about being starstruck when dealing with Nobel Prize-winning inventors, and how she deals with self-doubt
In the third episode of our monthly podcast, the Managing IP editorial team unpacks SEP news, the probe into Judge Pauline Newman, and the biggest stories elsewhere
In the second episode of our monthly podcast, the Managing IP editorial team unpacks a busy month at SCOTUS, the EU’s solution to the FRAND conundrum, and the biggest stories elsewhere
In the first of a new monthly podcast, the Managing IP editorial team unpacks the race for the top job at the EUIPO, the key UPC trends to watch, and the biggest stories in Asian IP
Phyllis Turner-Brim talks about her career, the need for balance in intellectual property policy and her passion for diversity and inclusion
Derek Gilliland, who became a magistrate judge at the Western District of Texas this month, delves into his work, thoughts on Alan Albright and ambitions
Kirupa Pushparaj talks about his move to a fintech start-up focused on young-person financial independence, career progression and start-up IP needs
Sources from the High Tech Inventors Alliance, the Senate Judiciary IP Subcommittee and NPE Dominion Harbor weigh in on the rise of the Western District of Texas
Heath Hoglund, chief patent counsel at Dolby in San Francisco, sits down with Managing IP to talk about licensing, FRAND and more
David Simon, senior vice president of IP at Salesforce, shares his views on Section 101, Fintiv, the DMCA, and more
The intellectual property CEO of one of the world's largest telecoms companies talks about licensing, harvesting collaboration and global outreach
ad ros bottom lb